Grail, Inc. (NL0)

Profile

https://grail.com

GRAIL, Inc. is a healthcare biotechnology company focused on early cancer detection. The company develops and commercializes blood-based screening products designed to identify signals from multiple cancer types before symptoms appear, supporting earlier clinical follow-up and diagnosis. Its primary offering, Galleri, is used in multi-cancer early detection and complements standard guideline-recommended screenings. GRAIL also applies genomics, machine learning, and large-scale clinical data to advance precision oncology applications such as risk stratification, minimal residual disease detection, biomarker subtyping, and recurrence monitoring. Headquartered in Menlo Park, California, GRAIL serves healthcare providers, health systems, and patients in the United States and internationally through its commercial-stage diagnostics business.